Literature DB >> 9950232

Protection of hamsters from amebic liver abscess formation by a monoclonal antibody to a 150-kDa surface lectin of Entamoeba histolytica.

X J Cheng1, H Tachibana, Y Kaneda.   

Abstract

We examined the effects of passive immunization with a monoclonal antibody (EH3015) that recognizes a 150-kDa surface lectin of Entamoeba histolytica on amebic liver-abscess formation in hamsters. The hamsters were inoculated i.p with 0.1, 1.0, or 10 mg of EH3015 at 24 h prior to an intrahepatic challenge with 10(5) trophozoites of E. histolytica. In hamsters treated with 1.0 and 10 mg of EH3015 the incidence of liver abscesses was significantly reduced. These results demonstrate that monoclonal antibody EH3015 can prevent the development of amebic liver abscesses and that the 150-kDa lectin may be a protective antigen on the surface of E. histolytica.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950232     DOI: 10.1007/s004360050510

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  8 in total

1.  Evaluation of recombinant fragments of Entamoeba histolytica Gal/GalNAc lectin intermediate subunit for serodiagnosis of amebiasis.

Authors:  Hiroshi Tachibana; Xun-Jia Cheng; Gohta Masuda; Noriyuki Horiki; Tsutomu Takeuchi
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Amebic cysteine proteinase 2 (EhCP2) plays either a minor or no role in tissue damage in acute experimental amebic liver abscess in hamsters.

Authors:  Alfonso Olivos-García; Augusto González-Canto; Rosario López-Vancell; Maria del Carmen García de León; Eusebio Tello; Mario Nequiz-Avendaño; Irmgard Montfort; Ruy Pérez-Tamayo
Journal:  Parasitol Res       Date:  2003-02-27       Impact factor: 2.289

3.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

4.  Characterization of Entamoeba histolytica intermediate subunit lectin-specific human monoclonal antibodies generated in transgenic mice expressing human immunoglobulin loci.

Authors:  Hiroshi Tachibana; Xun-Jia Cheng; Hideo Tsukamoto; Johbu Itoh
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

5.  Mucosal delivery of ACNPV baculovirus driving expression of the Gal-lectin LC3 fragment confers protection against amoebic liver abscess in hamster.

Authors:  D M Meneses-Ruiz; J P Laclette; H Aguilar-Díaz; J Hernández-Ruiz; A Luz-Madrigal; A Sampieri; L Vaca; J C Carrero
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

6.  Novel hemagglutinating, hemolytic and cytotoxic activities of the intermediate subunit of Entamoeba histolytica lectin.

Authors:  Kentaro Kato; Kazuhide Yahata; Bhim Gopal Dhoubhadel; Yoshito Fujii; Hiroshi Tachibana
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

7.  Comparison of hemolytic activity of the intermediate subunit of Entamoeba histolytica and Entamoeba dispar lectins.

Authors:  Kentaro Kato; Takashi Makiuchi; Xunjia Cheng; Hiroshi Tachibana
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

8.  Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.

Authors:  Xiangyang Min; Meng Feng; Yue Guan; Suqin Man; Yongfeng Fu; Xunjia Cheng; Hiroshi Tachibana
Journal:  PLoS Negl Trop Dis       Date:  2016-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.